Telangiectasis clinical trials
The registry lists 153 studies for Telangiectasis across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-15.
Status
- Completed
- 102
- Status unknown
- 20
- Recruiting
- 10
- Terminated
- 7
- Withdrawn
- 5
- Active, not recruiting
- 4
Phase
- Phase 2
- 38
- Phase 1
- 16
- Phase 3
- 11
- Phase 4
- 10
- Early Phase 1
- 1
Where
- United States
- 48
- United Kingdom
- 18
- Germany
- 13
- France
- 12
- Brazil
- 11
- Israel
- 9
Who runs them
Imperial College London (12) · Hospices Civils de Lyon (9) · Johann Wolfgang Goethe University Hospital (6) · Neurotech Pharmaceuticals (6) · University Hospital, Essen (5) · National Eye Institute (NEI) (4) · Unity Health Toronto (4) · National Center for Research Resources (NCRR) (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 153 — search for more.
- Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser TherapyRecruitingNCT07521462Not applicable1 country
- Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/21 country
- Comprehensive HHT Outcomes Registry of the United States (CHORUS)RecruitingNCT062592921 country
- Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS TechniqueRecruitingNCT07678697Not applicable1 country
- The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin ParametersNot yet recruitingNCT07345195Not applicable1 country
- CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb TelangiectasiasNot yet recruitingNCT07073742Phase 2
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Quality of Life in Patients With Hemorrhagic TelangiectasiaEnrolling by invitationNCT062613331 country
- Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic TelangiectasiaRecruitingNCT044695171 country
- Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide RibosideNot yet recruitingNCT06324877Not applicable1 country
- Home-based Complex Intervention for Children With Ataxia TelangiectasiaRecruitingNCT05692622Not applicable1 country
- Molecular Studies on Hereditary Haemorrhagic Telangiectasia FamiliesRecruitingNCT002306201 country
- Case Notes Review on Patients With Hereditary Haemorrhagic TelangiectasiaRecruitingNCT002306851 country
- Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic TelangiectasiaNot yet recruitingNCT03850730Phase 1/2
- Partial Breast Versus no Irradiation for Women With Early Breast CancerRecruitingNCT03646955Not applicable4 countries
- Sirolimus Treatment in Pediatric Patients With Ataxia-TelangiectasiaCompletedNCT07820579Phase 21 country
- Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and TelangiectasiasActive, not recruitingNCT07793630Phase 41 country
- Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic SclerodermaCompletedNCT05036200Not applicable1 country
- Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial IntelligenceCompletedNCT05978986Not applicable1 country
- Brimonidine 0.33% for Rosacea-Related Facial ErythemaCompletedNCT07431476Phase 41 country
- Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland DysfunctionCompletedNCT04425551Not applicable1 country
- Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)CompletedNCT03071965Phase 22 countries
- Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and TelangiectasiasCompletedNCT06962813Not applicable1 country
- Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT04646356Phase 21 country
- Doxycycline for Hereditary Hemorrhagic TelangiectasiaCompletedNCT03397004Phase 21 country
- Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT DatabaseActive, not recruitingNCT059333301 country
- Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2CompletedNCT04729972Phase 22 countries
- Genotype-phenotype Association in Hereditary Hemorrhagic TelangiectasiaCompletedNCT055503761 country
- Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With RosaceaCompletedNCT06582043Not applicable2 countries
- Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHTActive, not recruitingNCT038414221 country
- Hereditary Haemorrhagic Telangiectasia Flight Safety StudyCompletedNCT015901211 country
- Pomalidomide for the Treatment of Bleeding in HHTCompletedNCT03910244Phase 21 country
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol ACompletedNCT03316300Phase 34 countries
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol BCompletedNCT03319849Phase 33 countries
- Effect of Avastin in Juxtafoveal TelangiectasiasWithdrawnNCT00406380Phase 31 country
- Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia PatientsCompletedNCT02770807Phase 312 countries
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT019316441 country
- Diet and Hereditary Haemorrhagic TelangiectasiaCompletedNCT01692015Not applicable1 country
- Whole Body MRI for Cancer Surveillance in A-TCompletedNCT052528191 country
- Skin Imaging to Inform Laser TreatmentsTerminatedNCT04336163Not applicable1 country
- Lower Limb Sclerotherapy of Reticular Veins and TelangiectasiasCompletedNCT058604391 country
- Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of TelangiectasiaCompletedNCT04132323Not applicable1 country
- Investigation of Coagulation Parameters in Hereditary Haemorrhagic TelangiectasiaCompletedNCT002306591 country
- Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMsCompletedNCT02436213Not applicable1 country
- Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMsCompletedNCT002306721 country
- Frequency of Common Medical Conditions in People With and Without HHTCompletedNCT02464644Not applicable1 country
- Study of Histological Samples From Patients With Hereditary Haemorrhagic TelangiectasiaCompletedNCT007336551 country
- Iron Deficiency and Hereditary Haemorrhagic TelangiectasiaTerminatedNCT01908543Not applicable1 country
- Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of ConceptCompletedNCT01752049Phase 1/21 country
- Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABHCompletedNCT060391241 country